

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Treatment of Hypogonadism: Current and Future... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-68/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-68" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Treatment of Hypogonadism: Current and Future Therapies" />
    
            <meta name="og:title" content="F1000Research Article: Treatment of Hypogonadism: Current and Future Therapies.">
            <meta name="og:description" content="Read the latest article version by Arthi Thirumalai, Kathryn E. Berkseth, John K. Amory, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="10883">
            <meta name="article-id" content="10102">
            <meta name="dc.title" content="Treatment of Hypogonadism: Current and Future Therapies">
            <meta name="dc.description" content="The treatment of hypogonadism in men is of great interest to both patients and providers. There are a number of testosterone formulations currently available and several additional formulations under development. In addition, there are some lesser-used alternative therapies for the management of male hypogonadism, which may have advantages for certain patient groups. The future of hypogonadism therapy may lie in the development of selective androgen receptor modulators that allow the benefits of androgens whilst minimizing unwanted side effects.">
            <meta name="dc.subject" content="hypogonadism, testosterone therapy, dihydrotestosterone gel, selective androgen receptor modulator, aromatase inhibitor">
            <meta name="dc.creator" content="Thirumalai, Arthi">
            <meta name="dc.creator" content="Berkseth, Kathryn E.">
            <meta name="dc.creator" content="Amory, John K.">
            <meta name="dc.date" content="2017/01/23">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.10102.1">
            <meta name="dc.source" content="F1000Research 2017 6:68">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="hypogonadism">
            <meta name="prism.keyword" content="testosterone therapy">
            <meta name="prism.keyword" content="dihydrotestosterone gel">
            <meta name="prism.keyword" content="selective androgen receptor modulator">
            <meta name="prism.keyword" content="aromatase inhibitor">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/01/23">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="68">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.10102.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-68">
            <meta name="citation_title" content="Treatment of Hypogonadism: Current and Future Therapies">
            <meta name="citation_abstract" content="The treatment of hypogonadism in men is of great interest to both patients and providers. There are a number of testosterone formulations currently available and several additional formulations under development. In addition, there are some lesser-used alternative therapies for the management of male hypogonadism, which may have advantages for certain patient groups. The future of hypogonadism therapy may lie in the development of selective androgen receptor modulators that allow the benefits of androgens whilst minimizing unwanted side effects.">
            <meta name="citation_description" content="The treatment of hypogonadism in men is of great interest to both patients and providers. There are a number of testosterone formulations currently available and several additional formulations under development. In addition, there are some lesser-used alternative therapies for the management of male hypogonadism, which may have advantages for certain patient groups. The future of hypogonadism therapy may lie in the development of selective androgen receptor modulators that allow the benefits of androgens whilst minimizing unwanted side effects.">
            <meta name="citation_keywords" content="hypogonadism, testosterone therapy, dihydrotestosterone gel, selective androgen receptor modulator, aromatase inhibitor">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Arthi Thirumalai">
            <meta name="citation_author_institution" content="Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA">
            <meta name="citation_author" content="Kathryn E. Berkseth">
            <meta name="citation_author_institution" content="Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA">
            <meta name="citation_author" content="John K. Amory">
            <meta name="citation_author_institution" content="Center for Research in Reproduction and Contraception, Department of Medicine, University of Washington, Seattle, WA, USA">
            <meta name="citation_publication_date" content="2017/01/23">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="68">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.10102.1">
            <meta name="citation_firstpage" content="68">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-68/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-68.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=10883 /> <input type=hidden id=articleId name=articleId value=10102 /> <input type=hidden id=xmlUrl value="/articles/6-68/v1/xml"/> <input type=hidden id=xmlFileName value="-6-68-v1.xml"> <input type=hidden id=article_uuid value=822eeb52-bc28-4280-a3cf-32e1878ff1f8 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Treatment of Hypogonadism: Current and Future Therapies"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.10102.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.10102.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-68"
  },
  "headline": "Treatment of Hypogonadism: Current and Future Therapies",
  "datePublished": "2017-01-23T14:54:41",
  "dateModified": "2017-01-23T14:54:41",
  "author": [
    {
      "@type": "Person",
      "name": "Arthi Thirumalai"
    },    {
      "@type": "Person",
      "name": "Kathryn E. Berkseth"
    },    {
      "@type": "Person",
      "name": "John K. Amory"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "The treatment of hypogonadism in men is of great interest to both patients and providers. There are a number of testosterone formulations currently available and several additional formulations under development. In addition, there are some lesser-used alternative therapies for the management of male hypogonadism, which may have advantages for certain patient groups. The future of hypogonadism therapy may lie in the development of selective androgen receptor modulators that allow the benefits of androgens whilst minimizing unwanted side effects."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-68/v1",
            "name": "Treatment of Hypogonadism: Current and Future Therapies"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Treatment of Hypogonadism: Current and Future Therapies </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=10883 data-id=10102 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10102.1" data-recommended="" data-doi="10.12688/f1000research.10102.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-68/v1/pdf?article_uuid=822eeb52-bc28-4280-a3cf-32e1878ff1f8" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-10102-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-10102-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-10102-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Thirumalai A, Berkseth KE and Amory JK. Treatment of Hypogonadism: Current and Future Therapies [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):68 (<a class=new-orange href="https://doi.org/10.12688/f1000research.10102.1" target=_blank>https://doi.org/10.12688/f1000research.10102.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-10102-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=10102 id=track-article-signin-10102 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10102?target=/articles/6-68/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=10883 /> <input name=articleId type=hidden value=10102 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Treatment of Hypogonadism: Current and Future Therapies</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Arthi Thirumalai<sup>1</sup>,&nbsp;</span><span class="">Kathryn E. Berkseth<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:jamory@u.washington.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>John K. Amory</span></a><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Arthi Thirumalai<sup>1</sup>,&nbsp;</span><span class="">Kathryn E. Berkseth<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:jamory@u.washington.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>John K. Amory</span></a><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 23 Jan 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.10102.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA<br/> <sup>2</sup> Center for Research in Reproduction and Contraception, Department of Medicine, University of Washington, Seattle, WA, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=19924-19576></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=19925-19577></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> The treatment of hypogonadism in men is of great interest to both patients and providers. There are a number of testosterone formulations currently available and several additional formulations under development. In addition, there are some lesser-used alternative therapies for the management of male hypogonadism, which may have advantages for certain patient groups. The future of hypogonadism therapy may lie in the development of selective androgen receptor modulators that allow the benefits of androgens whilst minimizing unwanted side effects. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> hypogonadism, testosterone therapy, dihydrotestosterone gel, selective androgen receptor modulator, aromatase inhibitor </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> John K. Amory (<a href="mailto:jamory@u.washington.edu">jamory@u.washington.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> John K. Amory </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> John K. Amory has received research funding from Clarus Therapeutics. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported, in part, by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, a division of the National Institute of Health through cooperative agreement U54 HD04245 and K24 HD082231 (JKA). <br/> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Thirumalai A <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Thirumalai A, Berkseth KE and Amory JK. Treatment of Hypogonadism: Current and Future Therapies [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):68 (<a href="https://doi.org/10.12688/f1000research.10102.1" target=_blank>https://doi.org/10.12688/f1000research.10102.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 23 Jan 2017, <b>6</b>(F1000 Faculty Rev):68 (<a href="https://doi.org/10.12688/f1000research.10102.1" target=_blank>https://doi.org/10.12688/f1000research.10102.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 23 Jan 2017, <b>6</b>(F1000 Faculty Rev):68 (<a href="https://doi.org/10.12688/f1000research.10102.1" target=_blank>https://doi.org/10.12688/f1000research.10102.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d39547e188>Introduction</h2><p class="" id=d39547e191>The Endocrine Society Clinical Practice Guideline defines male hypogonadism as “a clinical syndrome that results from failure of the testes to produce physiological levels of testosterone due to disruption of one or more levels of the hypothalamic-pituitary-testicular axis”<sup><a href="#ref-1">1</a></sup>. Given that testosterone concentrations decline with age<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup> and the increasing awareness of the signs and symptoms of hypogonadism, prescriptions for testosterone therapy have increased significantly in the last several years<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d39547e209>In this review, we will briefly summarize the risks and benefits of testosterone replacement therapy. In addition, we will describe the existing options for testosterone therapy, including several newer formulations of testosterone under development. Lastly, we will discuss the data available on alternative therapies occasionally used for the treatment of male hypogonadism.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39547e215>Risks and benefits of testosterone therapy</h2><p class="" id=d39547e218>For men with symptomatic hypogonadism, there are a number of potential clinical benefits with testosterone replacement therapy, including improvements in libido, erectile function, muscle strength and body composition (including decreased fat mass, increased lean mass, and improved bone mineral density), mood, and cognition<sup><a href="#ref-1">1</a></sup>. The potential clinical benefits of testosterone therapy must be carefully weighed against potential risks. Potential adverse effects of testosterone replacement include erythrocytosis, increases in prostate-specific antigen (PSA) and worsening of prostate disorders (including benign prostatic hyperplasia [BPH]), dermatologic effects, including acne and skin irritation, and worsening of existing obstructive sleep apnea<sup><a href="#ref-1">1</a></sup>. In addition, exogenous testosterone administration leads to the suppression of luteinizing hormone (LH), decreased intra-testicular testosterone concentrations, and reduced spermatogenesis<sup><a href="#ref-5">5</a></sup>. Thus, testosterone replacement therapy is not appropriate for hypogonadal men desiring fertility.</p><p class="" id=d39547e233>Notably, the US Food and Drug Administration (FDA) has recently added important warnings to testosterone products. The first is a warning added to all testosterone preparations highlighting a potential increased risk of cardiovascular disease (including myocardial infarction and stroke) in patients taking testosterone, although additional studies are needed to guide clinicians in better understanding these potential risks, as the magnitude of these risks are unknown. However, until additional information becomes available, the current recommendation is that clinicians in practice should discuss these potential risks with all patients when starting or continuing testosterone replacement therapy<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>.</p><p class="" id=d39547e243>In October 2016, the FDA added additional warnings to the labeling of testosterone products to alert prescribers to the potential for abuse of testosterone and other anabolic androgenic steroids. The FDA statement outlined potential adverse effects of abuse of anabolic androgenic steroids, including myocardial infarction, heart failure, stroke, liver injury, male infertility, and mood changes including depression, aggression, and hostility. They also raised concerns that abuse of high doses of testosterone was reported to be associated with potential withdrawal symptoms including depression, irritability, fatigue, insomnia, and decreased libido. The potential for abuse of testosterone and other androgens should be considered in both adult and adolescent populations.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39547e249>Testosterone replacement therapy</h2><p class="" id=d39547e252>There are a variety of testosterone preparations currently on the market in the US (<a href="#T1">Table 1</a>) and additional formulations available abroad and in development (see below). In choosing the testosterone formulation for an individual patient, clinicians must consider the individual values and preferences of the patient as well as other factors including cost, convenience, and availability. Owing to their ease of use and relatively low cost, injectable and transdermal testosterone preparations are currently the most widely used in the US.</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Testosterone preparations.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d39547e269 class=n-a></a><thead><a name=d39547e271 class=n-a></a><tr><a name=d39547e273 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d39547e275 class=n-a></a>Formulation</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39547e278 class=n-a></a>Preparation (US<br class=br>trade name)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39547e283 class=n-a></a>Dosage Forms</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39547e286 class=n-a></a>Usual Dosing*</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39547e289 class=n-a></a>Site of<br class=br>Application</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39547e295 class=n-a></a>Advantages</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39547e298 class=n-a></a>Disadvantages and Risks</th><th align=left colspan=1 rowspan=1 valign=top><a name=d39547e301 class=n-a></a>Approximate<br class=br>Cost per<br class=br>Month**</th></tr><tr><a name=d39547e309 class=n-a></a><td align=left colspan=7 rowspan=1><a name=d39547e311 class=n-a></a><b>Intramuscular</b></td><td colspan=1 rowspan=1><a name=d39547e315 class=n-a></a></td></tr></thead><tbody><a name=d39547e319 class=n-a></a><tr><a name=d39547e321 class=n-a></a><td align=left colspan=1 rowspan=2 valign=top><a name=d39547e323 class=n-a></a>Intermediate<br class=br>acting</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e328 class=n-a></a>Testosterone<br class=br>cypionate (Depo-<br class=br>testosterone)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e335 class=n-a></a>100 mg/mL or 200 mg/mL</td><td align=left colspan=1 rowspan=2 valign=top><a name=d39547e338 class=n-a></a>100–200 mg every<br class=br>2 weeks or 50–100 mg<br class=br>every 1 week</td><td align=left colspan=1 rowspan=2 valign=top><a name=d39547e345 class=n-a></a>Thigh or buttock</td><td align=left colspan=1 rowspan=2 valign=top><a name=d39547e349 class=n-a></a>Home IM injection,<br class=br>infrequent treatment,<br class=br>low cost, high efficacy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e356 class=n-a></a>Peak effects/fluctuating<br class=br>testosterone levels,<br class=br>pain/irritation at injection site</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e363 class=n-a></a>$15–60 (generic)<br class=br>$50–70 (brand)</td></tr><tr><a name=d39547e369 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e371 class=n-a></a>Testosterone<br class=br>enanthate<br class=br>(Delatestryl)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e378 class=n-a></a>200 mg/mL</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e381 class=n-a></a>$15–35 (generic)<br class=br>$45–50 (brand)</td></tr><tr><a name=d39547e387 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e389 class=n-a></a>Long acting</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e392 class=n-a></a>Testosterone<br class=br>undecanoate<br class=br>(Aveed)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e399 class=n-a></a>250 mg/mL</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e402 class=n-a></a>750 mg initially, then<br class=br>750 mg at 4 weeks, then<br class=br>750 mg every 10 weeks<br class=br>ongoing</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e411 class=n-a></a>Buttock</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e415 class=n-a></a>Long acting</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e418 class=n-a></a>Administered in office/hospital<br class=br>by REMS-certified provider, risk<br class=br>of pulmonary oil microembolism<br class=br>and anaphylaxis</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e427 class=n-a></a>$1050 (plus<br class=br>cost of<br class=br>injection)</td></tr><tr><a name=d39547e435 class=n-a></a><td align=left colspan=7 rowspan=1><a name=d39547e437 class=n-a></a><b>Transdermal</b></td><td colspan=1 rowspan=1><a name=d39547e441 class=n-a></a></td></tr><tr><a name=d39547e444 class=n-a></a><td align=left colspan=1 rowspan=5 valign=top><a name=d39547e446 class=n-a></a>Gels</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e449 class=n-a></a>AndroGel (1% gel)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e452 class=n-a></a>25 mg in 2.5 g packet or<br class=br>50 mg in 5 g packet</td><td align=left colspan=1 rowspan=2 valign=top><a name=d39547e457 class=n-a></a>50–100 mg daily</td><td align=left colspan=1 rowspan=3 valign=top><a name=d39547e460 class=n-a></a>Dry intact skin or<br class=br>back, abdomen,<br class=br>upper thighs, or<br class=br>arm</td><td align=left colspan=1 rowspan=3 valign=top><a name=d39547e470 class=n-a></a>Steady serum<br class=br>testosterone<br class=br>concentration</td><td align=left colspan=1 rowspan=5 valign=top><a name=d39547e477 class=n-a></a>Risk of transfer, requires daily<br class=br>application, may not achieve<br class=br>normal T levels in all men,<br class=br>occasional skin irritation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e486 class=n-a></a>$175–400<br class=br>(generic)<br class=br>$500–525<br class=br>(brand)</td></tr><tr><a name=d39547e497 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e499 class=n-a></a>Testim (1% gel)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e502 class=n-a></a>50 mg in 5 gm packet</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e505 class=n-a></a>$160–320<br class=br>(generic)<br class=br>$480–520<br class=br>(brand)</td></tr><tr><a name=d39547e515 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e517 class=n-a></a>AndroGel (1.62%<br class=br>gel)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e522 class=n-a></a>20.25 mg in 1.25 g<br class=br>packet, 40.5 mg in 2.5<br class=br>g packet, 20.25 mg per<br class=br>actuation, metered dose<br class=br>pump</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e533 class=n-a></a>20.25–81 mg daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e536 class=n-a></a>$480–550<br class=br>(brand only)</td></tr><tr><a name=d39547e542 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e544 class=n-a></a>Fortesta (2% gel)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e547 class=n-a></a>10 mg per actuation,<br class=br>metered dose pump</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e552 class=n-a></a>10–70 mg daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e555 class=n-a></a>Dry intact skin of<br class=br>front and inner<br class=br>thighs</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e562 class=n-a></a>Ease of application</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e566 class=n-a></a>$160–400</td></tr><tr><a name=d39547e570 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e572 class=n-a></a>Axiron (2%<br class=br>solution)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e577 class=n-a></a>30 mg per actuation,<br class=br>metered-dose pump</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e582 class=n-a></a>30–120 mg daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e585 class=n-a></a>Dry, intact skin of<br class=br>axilla</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e590 class=n-a></a>Ease of application,<br class=br>reduced risk for transfer</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e596 class=n-a></a>$260–1,200</td></tr><tr><a name=d39547e600 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e602 class=n-a></a>Patch</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e605 class=n-a></a>Androderm</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e608 class=n-a></a>2 mg/24 hour patch<br class=br>4mg/24 hour patch</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e613 class=n-a></a>2–6 mg daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e616 class=n-a></a>Dry intact skin of<br class=br>arm or torso</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e622 class=n-a></a>Limited risk of transfer,<br class=br>no injection</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e627 class=n-a></a>Skin irritation/rash (about one-<br class=br>third of men), daily application</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e632 class=n-a></a>$475–510</td></tr><tr><a name=d39547e636 class=n-a></a><td align=left colspan=7 rowspan=1><a name=d39547e638 class=n-a></a><b>Other</b></td><td colspan=1 rowspan=1><a name=d39547e642 class=n-a></a></td></tr><tr><a name=d39547e646 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e648 class=n-a></a>Implanted<br class=br>Subcutaneous<br class=br>Pellet</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e655 class=n-a></a>Testopel</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e658 class=n-a></a>75 mg pellets</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e661 class=n-a></a>150–450 mg every 3–6<br class=br>months</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e666 class=n-a></a>Implanted into<br class=br>subcutaneous fat<br class=br>of buttock, lower<br class=br>abdominal wall,<br class=br>or thigh</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e678 class=n-a></a>No risk of transfer, no<br class=br>daily treatment</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e683 class=n-a></a>Extrusion, infection, fibrosis at<br class=br>pellet sites. Placed in clinic/<br class=br>hospital by trained provider<br class=br>under sterile conditions.</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e692 class=n-a></a>$150–175 (plus<br class=br>cost of pellet<br class=br>placement)<br class=br>cost estimate<br class=br>based on dose<br class=br>150 mg every<br class=br>3 months</td></tr><tr><a name=d39547e709 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e711 class=n-a></a>Nasal</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e714 class=n-a></a>Natesto</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e717 class=n-a></a>5.5 mg per actuation,<br class=br>metered dose pump<br class=br>applicator</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e724 class=n-a></a>11 mg (two pumps, one<br class=br>in each nostril) three<br class=br>times daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e731 class=n-a></a>Intranasal</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e735 class=n-a></a>Minimal risk of transfer</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e738 class=n-a></a>Frequent administration,<br class=br>rhinorrhea, epistaxis, sinusitis,<br class=br>nasal scab</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e745 class=n-a></a>$600–700</td></tr><tr><a name=d39547e749 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e751 class=n-a></a>Buccal</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e754 class=n-a></a>Striant SR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e757 class=n-a></a>30 mg buccal system</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e760 class=n-a></a>30 mg twice daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e763 class=n-a></a>Adhere to<br class=br>depression in the<br class=br>gingiva superior<br class=br>to upper incisors</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e773 class=n-a></a>No injection</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e776 class=n-a></a>Frequent administration,<br class=br>gingival irritation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e781 class=n-a></a>$550–600</td></tr><tr><a name=d39547e785 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e787 class=n-a></a>Oral<br class=br>(testosterone<br class=br>undecanoate)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e794 class=n-a></a>Andriol</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e797 class=n-a></a>40 mg</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e800 class=n-a></a>40–80 mg orally, three<br class=br>times daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e805 class=n-a></a>Oral, taken with<br class=br>fat-containing<br class=br>meal</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e813 class=n-a></a>No injection</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e816 class=n-a></a>Frequent dosing required,<br class=br>relatively low testosterone<br class=br>delivery</td><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e823 class=n-a></a>$200–$300</td></tr><tr><a name=d39547e827 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d39547e829 class=n-a></a>Oral (alkylated)</td><td align=center colspan=7 rowspan=1 valign=top><a name=d39547e832 class=n-a></a>Not recommended</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d39547e840 class=n-a></a><p id=d39547e842> *Usual doses are listed but dosing should be adjusted based on specific patient factors and clinician judgment. **Cost data based on average cost purchasing monthly supply, various suppliers as listed on goodrx.com at the time of publication and estimated costs at University of Washington Medical Center for facility-administered testosterone undecanoate and Testopel. IM, intramuscular; REMS, Risk Evaluation and Mitigation Strategy; T, testosterone. Table adapted with permission from <a href="#ref-44">44</a>.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39547e854>Injectable formulations</h2><p class="" id=d39547e857>Two intermediate-acting injectable testosterone formulations are currently available in the US market: testosterone enanthate and testosterone cypionate<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. These are usually dosed every 1–2 weeks. In contrast, a newer long-acting testosterone ester, testosterone undecanoate (“Nebido” in Europe and “Aveed” in the US), can be dosed every 6–12 weeks. All of these formulations are administered as intramuscular injections. The majority of patients are able to administer injections independently at home with the help of a partner. Intramuscular testosterone formulations are highly effective in improving symptoms of hypogonadism. Additional benefits of long-acting injectable preparations include low cost of therapy (as compared to other preparations) and they more reliably achieve therapeutic serum concentrations of testosterone (as compared to transdermal preparations), thus reducing the need for routine monitoring of serum testosterone concentrations during therapy. With testosterone enanthate and testosterone cypionate, testosterone concentration and clinical effects peak 1–2 days after the injection and wane over the subsequent 2 weeks<sup><a href="#ref-10">10</a></sup>. For some patients, the fluctuations in serum testosterone concentrations can lead to adverse impacts on mood, energy, and sexual function, which can be bothersome or disruptive. In these cases, alternate dosing using half the usual dose administered weekly (instead of full dose every 2 weeks) or use of an alternate testosterone preparation may be preferred.</p><p class="" id=d39547e871>In contrast, testosterone undecanoate achieves relatively stable testosterone concentrations. Unfortunately, the relative large volume of testosterone undecanoate injections can be associated with the risk of pulmonary oil microembolism and anaphylaxis, albeit rarely. As a result, testosterone undecanoate is available only through a Risk Evaluation and Mitigation Strategy (REMS) program and must be administered by a trained, registered care provider in an office or hospital setting – it cannot be self-administered at home by the patient.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39547e877>Transdermal formulations</h2><p class="" id=d39547e880>Transdermal testosterone gels are widely available and popular among both patients and clinicians. There are multiple transdermal gel formulations currently available in the US including AndroGel, Testim, Fortesta, and Axiron (<a href="#T1">Table 1</a>). They are supplied in sachets, tubes, or metered-dose pumps and are applied by hand to the skin of the arms, torso, or thighs. Newer concentrated testosterone preparations offer the advantage of applying a smaller volume of gel at each dose. Benefits of transdermal gels include high efficacy for the management of symptoms of hypogonadism, ease of home administration, and minimizing fluctuations in testosterone concentration from day to day. As a result, these formulations may be preferable for patients who struggle with peak and trough effects associated with the use of intermediate-term intramuscular injections. Risks of transdermal gels include mild skin irritation and potential for skin-to-skin transfer to others. All patients using gels should be instructed on careful hand washing after gel application and avoiding skin-to-skin contact with others (particularly female partners or children) on the gel-treated areas<sup><a href="#ref-11">11</a></sup>. In contrast to injectable testosterone preparations, absorption of transdermal testosterone gel can be quite variable. If a patient using a transdermal formulation of testosterone has no improvement in symptoms, it is reasonable to measure the serum testosterone concentration and adjust the dose as needed to achieve adequate circulating testosterone concentrations.</p><p class="" id=d39547e890>When the risk of skin-to-skin transfer of testosterone is of concern, the use of a transdermal patch may be appropriate. There is currently one transdermal testosterone patch preparation (Androderm) available in the US. Use of the patch has been limited by relatively high rates of skin irritation, with up to one-third of men who use the patch experiencing significant skin irritation. Similar to other transdermal testosterone preparations, monitoring of circulating serum testosterone concentration and appropriate dose adjustment are reasonable with transdermal patches, since testosterone absorption can be variable.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39547e897>Other testosterone formulations</h2><p class="" id=d39547e900>A subcutaneous testosterone pellet (Testopel) is available for the treatment of hypogonadism<sup><a href="#ref-12">12</a></sup>. Testopel is placed in the subcutaneous fat of the buttock, lower abdomen, or thigh every 3–6 months. Pellets are placed using sterile technique in an office or hospital setting and cannot be injected by the patient at home. Risks with subcutaneous testosterone pellets include infection, fibrosis, and pellet extrusion. Benefits include eliminating risk of skin-to-skin transfer, infrequent dosing, and relatively stable serum testosterone concentrations.</p><p class="" id=d39547e907>Nasal and buccal testosterone preparations are also available for the treatment of hypogonadism and may be useful in limited clinical settings where other testosterone preparations are not effective or appropriate. Use of nasal and buccal preparations is limited because of the potential for nasal/sinus and gingival irritation, limited published data on use of the nasal preparation, and animal studies suggesting possible increases in central nervous system testosterone levels above that expected with other formulations<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>.</p><p class="" id=d39547e917>Oral testosterone undecanoate (Andriol) is available in many countries outside the US; however, serum testosterone concentrations achieved with this formulation can be low and administration must occur with a fat-containing meal. New self-emulsifying drug formulations of testosterone undecanoate are under development and may reach the market in the next 1–2 years<sup><a href="#ref-15">15</a></sup>. However, high post-dose serum peaks and a relatively large degree of inter-individual variability in achieved drug concentrations are issues for these formulations. In response, the companies developing these newer formulations of testosterone undecanoate are developing dosing algorithms to ensure patients receive the appropriate dose to achieve therapeutic concentrations of testosterone. Other oral preparations, especially those alkylated at the 17-carbon position, such as methyltestosterone, are associated with hepatotoxicity and are not recommended for use.</p><p class="" id=d39547e924>Some newer testosterone formulations have recently come to the global market. These include both transdermal and injectable formulations. One of the transdermal formulations includes a hydro-alcoholic 2.5% testosterone gel (Testocur) that is approved for use in Germany. This drug was studied after application both transdermally and transscrotally, and compared with Androderm 2.5% patches applied transdermally in an open-label, parallel group, randomized controlled fashion in previously treated hypogonadal men for 24 weeks<sup><a href="#ref-16">16</a></sup>. While the scrotal gel and patches achieved equivalent serum androgen (testosterone and dihydrotestosterone [DHT]) concentrations, the transdermal gel actually achieved higher concentrations. The transdermal gel was also better tolerated than the patches whilst proving equivalent in safety outcomes such as hematocrit, serum PSA, and prostate volumes. Another formulation that is currently approved for use in Australia is an alcohol-free testosterone cream (AndroForte 5, 50 mg/mL or 5%, Lawley Pharmaceuticals)<sup><a href="#ref-17">17</a></sup>. This was studied in an open-label, randomized crossover study, comparing it with 1% testosterone gel in hypogonadal men with a treatment period of 30 days. Pharmacokinetic end points of both were comparable and there were no differences in serum hormone concentrations.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39547e938>Alternative therapies for treatment of male hypogonadism</h2><p class="" id=d39547e941>Given the concerns surrounding the safety and benefits of testosterone therapy in men, other agents have also been used for the treatment of male hypogonadism. In particular, in younger men who are interested in fertility, testosterone replacement therapy is not recommended.</p><div class=section><a name=d39547e944 class=n-a></a><h3 class=section-title>Dihydrotestosterone gel</h3><p class="" id=d39547e949>Testosterone is metabolized by 5α-reductase to DHT in the body. DHT has a stronger affinity than does testosterone for the androgen receptor in certain tissues such as the prostate, skin, and external genitalia. DHT gel is used for the treatment of hypogonadism in France and Belgium. The theoretical advantages of using DHT gel over testosterone in men would include mainly that (a) its use does not translate into increased intra-prostatic DHT concentrations and hence the risk of adverse prostate outcomes is lower<sup><a href="#ref-18">18</a></sup>, and (b) it is also not aromatized and hence gynecomastia is not a concern. Studies of DHT gel have also shown (like testosterone replacement) improved sexual function and muscle mass, lower fat mass<sup><a href="#ref-19">19</a></sup>, and favorable effects on lipid profiles<sup><a href="#ref-20">20</a></sup>. The downside to using DHT gel, however, includes the higher cost and the theoretical harm of lack of aromatization to estradiol (E2), which could impact bone mineral density and libido. Additionally, it is uncertain if the supra-physiologic serum DHT concentrations that are achieved with DHT gel<sup><a href="#ref-18">18</a></sup> can have long-term unfavorable effects of their own.</p></div><div class=section><a name=d39547e969 class=n-a></a><h3 class=section-title>Human chorionic gonadotropin</h3><p class="" id=d39547e974>In a healthy male, pulsatile gonadotropin-releasing hormone (GnRH) secretion stimulates follicle-stimulating hormone (FSH) and LH secretion from the pituitary, which in turn act on the Sertoli and Leydig cells, respectively, and support spermatogenesis and intra-testicular testosterone production<sup><a href="#ref-21">21</a></sup>. In hypogonadal men, the level to which spermatogenesis is impaired depends on both the etiology of hypogonadism and the time of onset (pre-pubertal versus post-pubertal), since that affects the baseline testicular volume and the number and functionality of germ cells. Human chorionic gonadotropin (hCG) therapy (recombinant hCG) is traditionally used in hypogonadal men desiring fertility, since it shares a receptor with LH and produces similar effects. The dose is usually titrated to a serum testosterone concentration in the mid-normal range. After 6 months of therapy, sperm concentrations are assessed and if no response is noted, then FSH therapy, either human menopausal gonadotropin (hMG) or recombinant human FSH (rhFSH), is added. Response times can be as long as 1–2 years for the combination, and success is higher in men with testicular volumes &gt;8 cc and later onset of hypogonadism<sup><a href="#ref-22">22</a></sup>. Studies have also looked at the role of hCG therapy in the treatment of hypogonadism in men without fertility concerns, and it has been shown to improve hypogonadal symptoms<sup><a href="#ref-23">23</a></sup> and have favorable effects on body composition (increased fat-free mass and lower fat mass), lipid profile (lower total cholesterol, low-density lipoprotein cholesterol, and triglycerides)<sup><a href="#ref-24">24</a></sup> and bone formation<sup><a href="#ref-25">25</a></sup>. hCG therapy also seems to be less likely to cause the adverse effects that testosterone is associated with in terms of prostate health, hematocrit, sleep apnea, and gynecomastia; however, it entails more frequent (2–3 times a week) injections than does testosterone and can also cause testicular enlargement<sup><a href="#ref-26">26</a></sup>.</p></div><div class=section><a name=d39547e1003 class=n-a></a><h3 class=section-title>Clomiphene citrate</h3><p class="" id=d39547e1008>Clomiphene is a selective estrogen receptor modulator that has weak anti-estrogen action. It competes with estrogen for binding at the estrogen receptor and increases GnRH secretion, thereby increasing LH secretion<sup><a href="#ref-27">27</a></sup> and consequently serum testosterone concentrations. For this reason, it works only in individuals with hypogonadotropic hypogonadism with an otherwise intact hypothalamic-pituitary-gonadal axis. In addition to improving serum testosterone levels, it has been shown to improve hypogonadal symptoms<sup><a href="#ref-21">21</a>,<a href="#ref-28">28</a></sup> and improve bone mineral density while avoiding adverse effects on PSA and hematocrit and gynecomastia<sup><a href="#ref-29">29</a></sup> and may be more economical than testosterone therapy<sup><a href="#ref-30">30</a></sup>. Though it seems a viable alternative to testosterone, it is not FDA approved for use in the treatment of hypogonadism. Potential drawbacks include an increased risk of thromboembolism as seen with other selective estrogen-receptor modulators, such as raloxifene, and a diminution of estrogen effects in the male, including effects on libido and bone mineral density.</p><p class="" id=d39547e1030>Enclomiphene is the <i>trans</i>-isomer of clomiphene. It is being studied as a treatment for hypogonadism in men with intact pituitary who wish to retain spermatogenesis during treatment. Several studies support the contention that spermatogenesis is better preserved with this approach<sup><a href="#ref-31">31</a>,<a href="#ref-32">32</a></sup>, but limited data on fertility preservation are available. As a result, this medication has not yet been approved for clinical use but is an interesting compound for future study in men who wish to maintain sperm production during treatment for hypogonadism.</p></div><div class=section><a name=d39547e1045 class=n-a></a><h3 class=section-title>Aromatase inhibitors</h3><p class="" id=d39547e1050>Aromatase converts testosterone to E2 in various tissues, particularly fat. Aromatase inhibitors prevent this and lower E2<sup><a href="#ref-33">33</a></sup>, which in turn prevents feedback inhibition of GnRH and causes increased release, thereby raising serum testosterone concentrations as well as intra-testicular testosterone. Agents such as letrozole and anastrozole have been investigated for the treatment of male hypogonadism. These have uniformly shown an increase in serum testosterone concentrations<sup><a href="#ref-33">33</a>–<a href="#ref-35">35</a></sup> and some have reported improvement in sexual desire<sup><a href="#ref-34">34</a></sup>, lean mass, muscle strength, and physical function<sup><a href="#ref-36">36</a></sup>. The other advantages of aromatase inhibitors over testosterone therapy are that the lower estrogen state does not increase prostate volume or lower urinary tract symptoms (LUTS)<sup><a href="#ref-37">37</a></sup> and it does not lower, or may even improve, sperm parameters<sup><a href="#ref-38">38</a></sup>. These factors make them a possible alternative to testosterone in obese hypogonadal men with high E2 concentrations, older hypogonadal men with BPH, and younger hypogonadal and subfertile men. However, the effect of lowering E2 levels can cause adverse effects on bone mineral density<sup><a href="#ref-36">36</a>,<a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup>, while other studies have shown no such effects<sup><a href="#ref-41">41</a></sup>. Also, recent studies have highlighted the importance of E2 in maintaining sexual desire<sup><a href="#ref-42">42</a></sup> and so lowering E2 concentrations in hypogonadal men may affect symptom improvement significantly.</p></div><div class=section><a name=d39547e1100 class=n-a></a><h3 class=section-title>Selective androgen receptor modulators</h3><p class="" id=d39547e1105>Androgen therapies mostly have beneficial effects on skeletal muscle and bone; however, they tend to cause negative effects on erythrocytes (erythrocytosis), prostate (BPH), hair (alopecia), and skin (acne). Therefore, an ideal therapeutic agent for the treatment of hypogonadism would have tissue-specific effects so that we can achieve the “good” without incurring the “bad”. This is the concept from which the development of selective androgen receptor modulators (SARMs) has stemmed. These agents act as tissue-specific androgen-receptor ligands, mainly acting at the level of skeletal tissue or bone. Studies have looked at their role in the treatment of chronic disease or cancer cachexia, frailty, sarcopenia, osteoporosis, hypogonadism, prostate cancer, and male contraception<sup><a href="#ref-43">43</a></sup>, but these are mostly pre-clinical or early-phase clinical studies of short duration. Rodent models have shown anabolic effects on muscle and bone with reduced impact on prostate growth as well as improvement in sexual behavior<sup><a href="#ref-44">44</a></sup>. One promising 12-week, double-blinded, placebo-controlled phase 2 trial of GTx-024 (enobosarm) in 120 healthy men older than 60 years of age showed dose-dependent increases in total lean body mass and improvement in physical function and insulin resistance<sup><a href="#ref-45">45</a></sup>. However, there is not enough evidence to recommend these as an alternative to testosterone for the treatment of hypogonadism as yet.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39547e1124>Challenges for alternative testosterone therapies for hypogonadism</h2><p class="" id=d39547e1127>While alternatives to testosterone therapy have appeal, particularly for men wishing to avoid suppression of spermatogenesis by testosterone, there is greater uncertainly regarding their risks and benefits, as they have been less well studied. In addition, FDA approval for these therapies has been difficult to obtain, as the FDA has indicated that raising testosterone is not acceptable as a primary endpoint for non-testosterone therapies. Instead, the FDA requires data on improvement of the signs and symptoms of hypogonadism<sup><a href="#ref-46">46</a></sup>. Such studies will likely require larger samples and better outcome measures, work that is somewhat hampered by the paucity of validated patient-reported outcome measures in the field.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39547e1137>Conclusions</h2><p class="" id=d39547e1140>Treatment of male hypogonadism remains an area that requires in-depth discussion of the risks and benefits of therapy with the patient before proceeding. With the numerous testosterone formulations that exist and are being developed, patients have a variety of options to choose from, depending on their preferences. Additionally, there are a number of non-testosterone alternative therapies too that can be considered, particularly in men desiring fertility or wishing to avoid specific side effects of testosterone therapy. Still newer therapies, currently in the stages of early clinical trials (selective androgen receptor modulators), may indeed be the future of androgen replacement therapy and hint at the promise of more benefits than harm, which would simplify these patient discussions and decisions.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39547e1146>Abbreviations</h2><p class="" id=d39547e1149>BPH, benign prostatic hyperplasia; DHT, dihydrotestosterone; E2, estradiol; FDA, US Food and Drug Administration; FSH, follicle-stimulating hormone; GnRH, gonadotropin-releasing hormone; hCG, human chorionic gonadotropin; hMG, human menopausal gonadotropin; LH, luteinizing hormone; LUTS, lower urinary tract symptoms; PSA, prostate-specific antigen; REMS, Risk Evaluation and Mitigation Strategy; rhFSH, recombinant human follicle-stimulating hormone; SARMs, selective androgen receptor modulators.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d39547e1 class=n-a></a><h2 class=main-title id=d39707>Competing interests</h2><p class=metadata-entry><a name=d39547e111 class=n-a></a><p id=d39547e113> John K. Amory has received research funding from Clarus Therapeutics.</p></p></div><div class=back-section><a name=d39547e1 class=n-a></a><h2 class=main-title id=d39709>Grant information</h2><p>This work was supported, in part, by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, a division of the National Institute of Health through cooperative agreement U54 HD04245 and K24 HD082231 (JKA).</p></div><div class=back-section><a name=d39547e1156 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d39854>References</h2><div class="section ref-list"><a name=d39547e1156 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d39547e1163 class=n-a></a>Bhasin S, Cunningham GR, Hayes FJ, <i> et al.</i>: Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. <i>J Clin Endocrinol Metab.</i> 2010; <b>95</b>(6): 2536–59. <a target=xrefwindow id=d39547e1174 href="http://www.ncbi.nlm.nih.gov/pubmed/20525905">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1177 href="http://dx.doi.org/10.1210/jc.2009-2354">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d39547e1186 class=n-a></a>Harman SM, Metter EJ, Tobin JD, <i> et al.</i>: Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. <i>J Clin Endocrinol Metab.</i> 2001; <b>86</b>(2): 724–31. <a target=xrefwindow id=d39547e1197 href="http://www.ncbi.nlm.nih.gov/pubmed/11158037">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1200 href="http://dx.doi.org/10.1210/jcem.86.2.7219">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d39547e1209 class=n-a></a>Feldman HA, Longcope C, Derby CA, <i> et al.</i>: Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. <i>J Clin Endocrinol Metab.</i> 2002; <b>87</b>(3): 589–98. <a target=xrefwindow id=d39547e1220 href="http://www.ncbi.nlm.nih.gov/pubmed/11836290">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1223 href="http://dx.doi.org/10.1210/jcem.87.2.8201">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d39547e1232 class=n-a></a>Tan RS, Salazar JA: Risks of testosterone replacement therapy in ageing men. <i>Expert Opin Drug Saf.</i> 2004; <b>3</b>(6): 599–606. <a target=xrefwindow id=d39547e1240 href="http://www.ncbi.nlm.nih.gov/pubmed/15500418">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1243 href="http://dx.doi.org/10.1517/14740338.3.6.599">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d39547e1252 class=n-a></a>Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. <i>Lancet.</i> 1990; <b>336</b>(8721): 955–9. <a target=xrefwindow id=d39547e1260 href="http://www.ncbi.nlm.nih.gov/pubmed/1977002">PubMed Abstract </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725793391"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e1270 class=n-a></a>Goodman N, Guay A, Dandona P, <i> et al.</i>: American Association of Clinical Endocrinologists and American College of Endocrinology position statement On The Association Of Testosterone And Cardiovascular Risk. <i>Endocr Pract.</i> 2015; <b>21</b>(9): 1066–73. <a target=xrefwindow id=d39547e1281 href="http://www.ncbi.nlm.nih.gov/pubmed/26355962">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1284 href="http://dx.doi.org/10.4158/EP14434.PS">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725793391">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725335331"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e1297 class=n-a></a>Morgentaler A, Miner MM, Caliber M, <i> et al.</i>: Testosterone therapy and cardiovascular risk: advances and controversies. <i>Mayo Clin Proc.</i> 2015; <b>90</b>(2): 224–51. <a target=xrefwindow id=d39547e1308 href="http://www.ncbi.nlm.nih.gov/pubmed/25636998">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1311 href="http://dx.doi.org/10.1016/j.mayocp.2014.10.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725335331">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d39547e1324 class=n-a></a>Snyder PJ, Lawrence DA: Treatment of male hypogonadism with testosterone enanthate. <i>J Clin Endocrinol Metab.</i> 1980; <b>51</b>(6): 1335–9. <a target=xrefwindow id=d39547e1332 href="http://www.ncbi.nlm.nih.gov/pubmed/6777395">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1335 href="http://dx.doi.org/10.1210/jcem-51-6-1335">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d39547e1344 class=n-a></a>Sih R, Morley JE, Kaiser FE, <i> et al.</i>: Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. <i>J Clin Endocrinol Metab.</i> 1997; <b>82</b>(6): 1661–7. <a target=xrefwindow id=d39547e1355 href="http://www.ncbi.nlm.nih.gov/pubmed/9177359">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1358 href="http://dx.doi.org/10.1210/jcem.82.6.3988">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d39547e1367 class=n-a></a>Schürmeyer T, Nieschlag E: Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal men. <i>Int J Androl.</i> 1984; <b>7</b>(3): 181–7. <a target=xrefwindow id=d39547e1375 href="http://www.ncbi.nlm.nih.gov/pubmed/6434435">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1378 href="http://dx.doi.org/10.1111/j.1365-2605.1984.tb00775.x">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d39547e1387 class=n-a></a>Swerdloff RS, Wang C, Cunningham G, <i> et al.</i>: Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. <i>J Clin Endocrinol Metab.</i> 2000; <b>85</b>(12): 4500–10. <a target=xrefwindow id=d39547e1398 href="http://www.ncbi.nlm.nih.gov/pubmed/11134099">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1401 href="http://dx.doi.org/10.1210/jcem.85.12.7045">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/14267117"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e1411 class=n-a></a>McCullough AR, Khera M, Goldstein I, <i> et al.</i>: A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertion. <i>J Sex Med.</i> 2012; <b>9</b>(2): 594–601. <a target=xrefwindow id=d39547e1422 href="http://www.ncbi.nlm.nih.gov/pubmed/22240203">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1425 href="http://dx.doi.org/10.1111/j.1743-6109.2011.02570.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/14267117">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727214352"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e1438 class=n-a></a>Rogol AD, Tkachenko N, Bryson N: Natesto<sup>TM</sup>, a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men. <i>Andrology.</i> 2016; <b>4</b>(1): 46–54. <a target=xrefwindow id=d39547e1449 href="http://www.ncbi.nlm.nih.gov/pubmed/26695758">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1452 href="http://dx.doi.org/10.1111/andr.12137">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727214352">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d39547e1465 class=n-a></a>Wang C, Swerdloff R, Kipnes M, <i> et al.</i>: New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. <i>J Clin Endocrinol Metab.</i> 2004; <b>89</b>(8): 3821–9. <a target=xrefwindow id=d39547e1476 href="http://www.ncbi.nlm.nih.gov/pubmed/15292312">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1479 href="http://dx.doi.org/10.1210/jc.2003-031866">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d39547e1488 class=n-a></a>Yin AY, Htun M, Swerdloff RS, <i> et al.</i>: Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation. <i>J Androl.</i> 2012; <b>33</b>(2): 190–201. <a target=xrefwindow id=d39547e1499 href="http://www.ncbi.nlm.nih.gov/pubmed/21474786">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1502 href="http://dx.doi.org/10.2164/jandrol.111.013169">Publisher Full Text </a> | <a target=xrefwindow id=d39547e1506 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4168025">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d39547e1515 class=n-a></a>Kühnert B, Byrne M, Simoni M, <i> et al.</i>: Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial. <i>Eur J Endocrinol.</i> 2005; <b>153</b>(2): 317–26. <a target=xrefwindow id=d39547e1526 href="http://www.ncbi.nlm.nih.gov/pubmed/16061839">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1529 href="http://dx.doi.org/10.1530/eje.1.01964">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727214353"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e1538 class=n-a></a>Wittert GA, Harrison RW, Buckley MJ, <i> et al.</i>: An open-label, phase 2, single centre, randomized, crossover design bioequivalence study of AndroForte 5 testosterone cream and Testogel 1% testosterone gel in hypogonadal men: study LP101. <i>Andrology.</i> 2016; <b>4</b>(1): 41–5. <a target=xrefwindow id=d39547e1549 href="http://www.ncbi.nlm.nih.gov/pubmed/26754331">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1552 href="http://dx.doi.org/10.1111/andr.12129">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727214353">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d39547e1566 class=n-a></a>Page ST, Lin DW, Mostaghel EA, <i> et al.</i>: Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial. <i>J Clin Endocrinol Metab.</i> 2011; <b>96</b>(2): 430–7. <a target=xrefwindow id=d39547e1577 href="http://www.ncbi.nlm.nih.gov/pubmed/21177791">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1580 href="http://dx.doi.org/10.1210/jc.2010-1865">Publisher Full Text </a> | <a target=xrefwindow id=d39547e1584 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3048323">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727214354"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e1593 class=n-a></a>Aydogdu A, Swerdloff RS: Emerging medication for the treatment of male hypogonadism. <i>Expert Opin Emerg Drugs.</i> 2016; <b>21</b>(3): 255–66. <a target=xrefwindow id=d39547e1601 href="http://www.ncbi.nlm.nih.gov/pubmed/27552127">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1604 href="http://dx.doi.org/10.1080/14728214.2016.1226799">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727214354">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d39547e1617 class=n-a></a>Ly LP, Jimenez M, Zhuang TN, <i> et al.</i>: A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. <i>J Clin Endocrinol Metab.</i> 2001; <b>86</b>(9): 4078–88. <a target=xrefwindow id=d39547e1628 href="http://www.ncbi.nlm.nih.gov/pubmed/11549629">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1631 href="http://dx.doi.org/10.1210/jcem.86.9.7821">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d39547e1640 class=n-a></a>Santen RJ, Leonard JM, Sherins RJ, <i> et al.</i>: Short- and long-term effects of clomiphene citrate on the pituitary-testicular axis. <i>J Clin Endocrinol Metab.</i> 1971; <b>33</b>(6): 970–9. <a target=xrefwindow id=d39547e1651 href="http://www.ncbi.nlm.nih.gov/pubmed/5135636">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1654 href="http://dx.doi.org/10.1210/jcem-33-6-970">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d39547e1663 class=n-a></a>George B, Bantwal G: Endocrine management of male subfertility. <i>Indian J Endocrinol Metab.</i> 2013; <b>17</b>(Suppl 1): S32–4. <a target=xrefwindow id=d39547e1671 href="http://www.ncbi.nlm.nih.gov/pubmed/24251201">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1674 href="http://dx.doi.org/10.4103/2230-8210.119500">Publisher Full Text </a> | <a target=xrefwindow id=d39547e1677 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3830347">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d39547e1686 class=n-a></a>Young J, Couzinet B, Chanson P, <i> et al.</i>: Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. <i>J Clin Endocrinol Metab.</i> 2000; <b>85</b>(9): 3239–44. <a target=xrefwindow id=d39547e1697 href="http://www.ncbi.nlm.nih.gov/pubmed/10999815">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1700 href="http://dx.doi.org/10.1210/jcem.85.9.6811">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d39547e1710 class=n-a></a>Liu PY, Wishart SM, Handelsman DJ: A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. <i>J Clin Endocrinol Metab.</i> 2002; <b>87</b>(7): 3125–35. <a target=xrefwindow id=d39547e1718 href="http://www.ncbi.nlm.nih.gov/pubmed/12107212">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1721 href="http://dx.doi.org/10.1210/jcem.87.7.8630">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d39547e1730 class=n-a></a>Meier C, Liu PY, Ly LP, <i> et al.</i>: Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency. <i>J Clin Endocrinol Metab.</i> 2004; <b>89</b>(6): 3033–41. <a target=xrefwindow id=d39547e1741 href="http://www.ncbi.nlm.nih.gov/pubmed/15181095">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1744 href="http://dx.doi.org/10.1210/jc.2003-031992">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d39547e1753 class=n-a></a>Burris AS, Rodbard HW, Winters SJ, <i> et al.</i>: Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. <i>J Clin Endocrinol Metab.</i> 1988; <b>66</b>(6): 1144–51. <a target=xrefwindow id=d39547e1764 href="http://www.ncbi.nlm.nih.gov/pubmed/3372679">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1767 href="http://dx.doi.org/10.1210/jcem-66-6-1144">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d39547e1776 class=n-a></a>Maggi M, Buvat J, Corona G, <i> et al.</i>: Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA). <i>J Sex Med.</i> 2013; <b>10</b>(3): 661–77. <a target=xrefwindow id=d39547e1787 href="http://www.ncbi.nlm.nih.gov/pubmed/22524444">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1790 href="http://dx.doi.org/10.1111/j.1743-6109.2012.02735.x">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d39547e1799 class=n-a></a>Shabsigh A, Kang Y, Shabsign R, <i> et al.</i>: Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. <i>J Sex Med.</i> 2005; <b>2</b>(5): 716–21. <a target=xrefwindow id=d39547e1810 href="http://www.ncbi.nlm.nih.gov/pubmed/16422830">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1813 href="http://dx.doi.org/10.1111/j.1743-6109.2005.00075.x">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d39547e1822 class=n-a></a>Moskovic DJ, Katz DJ, Akhavan A, <i> et al.</i>: Clomiphene citrate is safe and effective for long-term management of hypogonadism. <i>BJU Int.</i> 2012; <b>110</b>(10): 1524–8. <a target=xrefwindow id=d39547e1833 href="http://www.ncbi.nlm.nih.gov/pubmed/22458540">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1836 href="http://dx.doi.org/10.1111/j.1464-410X.2012.10968.x">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1165844"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e1846 class=n-a></a>Taylor F, Levine L: Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost. <i>J Sex Med.</i> 2010; <b>7</b>(1 Pt 1): 269–76. <a target=xrefwindow id=d39547e1854 href="http://www.ncbi.nlm.nih.gov/pubmed/19694928">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1857 href="http://dx.doi.org/10.1111/j.1743-6109.2009.01454.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1165844">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718498932"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e1870 class=n-a></a>Wiehle RD, Fontenot GK, Wike J, <i> et al.</i>: Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. <i>Fertil Steril.</i> 2014; <b>102</b>(3): 720–7. <a target=xrefwindow id=d39547e1881 href="http://www.ncbi.nlm.nih.gov/pubmed/25044085">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1884 href="http://dx.doi.org/10.1016/j.fertnstert.2014.06.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718498932">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727214355"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e1897 class=n-a></a>Kim ED, McCullough A, Kaminetsky J: Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. <i>BJU Int.</i> 2016; <b>117</b>(4): 677–85. <a target=xrefwindow id=d39547e1905 href="http://www.ncbi.nlm.nih.gov/pubmed/26496621">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1908 href="http://dx.doi.org/10.1111/bju.13337">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727214355">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d39547e1921 class=n-a></a>Loves S, Ruinemans-Koerts J, Boer H de: Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism. <i>Eur J Endocrinol.</i> 2008; <b>158</b>(5): 741–7. <a target=xrefwindow id=d39547e1929 href="http://www.ncbi.nlm.nih.gov/pubmed/18426834">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1932 href="http://dx.doi.org/10.1530/EJE-07-0663">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d39547e1941 class=n-a></a>Richardson D, Goldmeier D, Frize G, <i> et al.</i>: Letrozole versus testosterone. a single-center pilot study of HIV-infected men who have sex with men on highly active anti-retroviral therapy (HAART) with hypoactive sexual desire disorder and raised estradiol levels. <i>J Sex Med.</i> 2007; <b>4</b>(2): 502–8. <a target=xrefwindow id=d39547e1952 href="http://www.ncbi.nlm.nih.gov/pubmed/17367446">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1955 href="http://dx.doi.org/10.1111/j.1743-6109.2007.00451.x">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d39547e1964 class=n-a></a>Leder BZ, Finkelstein JS: Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. <i>Osteoporos Int.</i> 2005; <b>16</b>(12): 1487–94. <a target=xrefwindow id=d39547e1972 href="http://www.ncbi.nlm.nih.gov/pubmed/15856361">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1975 href="http://dx.doi.org/10.1007/s00198-005-1890-8">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727214356"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e1985 class=n-a></a>Dias JP, Melvin D, Simonsick EM, <i> et al.</i>: Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial. <i>Andrology.</i> 2016; <b>4</b>(1): 33–40. <a target=xrefwindow id=d39547e1996 href="http://www.ncbi.nlm.nih.gov/pubmed/26588809">PubMed Abstract </a> | <a target=xrefwindow id=d39547e1999 href="http://dx.doi.org/10.1111/andr.12126">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727214356">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726197631"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e2012 class=n-a></a>Dias JP, Melvin D, Shardell M, <i> et al.</i>: Effects of Transdermal Testosterone Gel or an Aromatase Inhibitor on Prostate Volume in Older Men. <i>J Clin Endocrinol Metab.</i> 2016; <b>101</b>(4): 1865–71. <a target=xrefwindow id=d39547e2023 href="http://www.ncbi.nlm.nih.gov/pubmed/26950683">PubMed Abstract </a> | <a target=xrefwindow id=d39547e2026 href="http://dx.doi.org/10.1210/jc.2016-1111">Publisher Full Text </a> | <a target=xrefwindow id=d39547e2030 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4880169">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726197631">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727214359"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e2043 class=n-a></a>Ribeiro MA, Gameiro LF, Scarano WR, <i> et al.</i>: Aromatase inhibitors in the treatment of oligozoospermic or azoospermic men: a systematic review of randomized controlled trials. <i>JBRA Assist Reprod.</i> 2016; <b>20</b>(2): 82–8. <a target=xrefwindow id=d39547e2054 href="http://www.ncbi.nlm.nih.gov/pubmed/27244767">PubMed Abstract </a> | <a target=xrefwindow id=d39547e2057 href="http://dx.doi.org/10.5935/1518-0557.20160019">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727214359">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/2196956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e2070 class=n-a></a>Burnett-Bowie SM, McKay EA, Lee H, <i> et al.</i>: Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. <i>J Clin Endocrinol Metab.</i> 2009; <b>94</b>(12): 4785–92. <a target=xrefwindow id=d39547e2081 href="http://www.ncbi.nlm.nih.gov/pubmed/19820017">PubMed Abstract </a> | <a target=xrefwindow id=d39547e2084 href="http://dx.doi.org/10.1210/jc.2009-0739">Publisher Full Text </a> | <a target=xrefwindow id=d39547e2088 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2795655">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/2196956">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d39547e2101 class=n-a></a>Hero M, Toiviainen-Salo S, Wickman S, <i> et al.</i>: Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty. <i>J Bone Miner Res.</i> 2010; <b>25</b>(7): 1536–43. <a target=xrefwindow id=d39547e2112 href="http://www.ncbi.nlm.nih.gov/pubmed/20200972">PubMed Abstract </a> | <a target=xrefwindow id=d39547e2115 href="http://dx.doi.org/10.1002/jbmr.56">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1103617"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e2124 class=n-a></a>Eastell R, Adams JE, Coleman RE, <i> et al.</i>: Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. <i>J Clin Oncol.</i> 2008; <b>26</b>(7): 1051–7. <a target=xrefwindow id=d39547e2135 href="http://www.ncbi.nlm.nih.gov/pubmed/18309940">PubMed Abstract </a> | <a target=xrefwindow id=d39547e2138 href="http://dx.doi.org/10.1200/JCO.2007.11.0726">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1103617">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d39547e2152 class=n-a></a>Finkelstein JS, Yu EW, Burnett-Bowie SM: Gonadal steroids and body composition, strength, and sexual function in men. <i>N Engl J Med.</i> 2013; <b>369</b>(25): 2455–2457. <a target=xrefwindow id=d39547e2160 href="http://www.ncbi.nlm.nih.gov/pubmed/24350954">PubMed Abstract </a> | <a target=xrefwindow id=d39547e2163 href="http://dx.doi.org/10.1056/NEJMc1313169">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d39547e2172 class=n-a></a>Zhang X, Sui Z: Deciphering the selective androgen receptor modulators paradigm. <i>Expert Opin Drug Discov.</i> 2013; <b>8</b>(2): 191–218. <a target=xrefwindow id=d39547e2180 href="http://www.ncbi.nlm.nih.gov/pubmed/23231475">PubMed Abstract </a> | <a target=xrefwindow id=d39547e2183 href="http://dx.doi.org/10.1517/17460441.2013.741582">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1081963"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39547e2192 class=n-a></a>Miner JN, Chang W, Chapman MS, <i> et al.</i>: An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. <i>Endocrinology.</i> 2007; <b>148</b>(1): 363–73. <a target=xrefwindow id=d39547e2203 href="http://www.ncbi.nlm.nih.gov/pubmed/17023534">PubMed Abstract </a> | <a target=xrefwindow id=d39547e2206 href="http://dx.doi.org/10.1210/en.2006-0793">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1081963">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d39547e2219 class=n-a></a>Dalton JT, Barnette KG, Bohl CE, <i> et al.</i>: The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. <i>J Cachexia Sarcopenia Muscle.</i> 2011; <b>2</b>(3): 153–61. <a target=xrefwindow id=d39547e2230 href="http://www.ncbi.nlm.nih.gov/pubmed/22031847">PubMed Abstract </a> | <a target=xrefwindow id=d39547e2233 href="http://dx.doi.org/10.1007/s13539-011-0034-6">Publisher Full Text </a> | <a target=xrefwindow id=d39547e2237 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3177038">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d39547e2246 class=n-a></a>FDA Briefing Document. Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) December 6, 2016. <a target=xrefwindow id=d39547e2248 href="http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/reproductivehealthdrugsadvisorycommittee/ucm530330.pdf">Reference Source</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Jan 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-68/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-68/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA<br/> <sup>2</sup> Center for Research in Reproduction and Contraception, Department of Medicine, University of Washington, Seattle, WA, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-68/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 23 Jan 2017, 6:68 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.10102.1">https://doi.org/10.12688/f1000research.10102.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Thirumalai A <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=10883 data-id=10102 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10102.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-68/v1/pdf?article_uuid=822eeb52-bc28-4280-a3cf-32e1878ff1f8" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.10102.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Thirumalai A, Berkseth KE and Amory JK. Treatment of Hypogonadism: Current and Future Therapies [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):68 (<a href="https://doi.org/10.12688/f1000research.10102.1" target=_blank>https://doi.org/10.12688/f1000research.10102.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=10102 id=mobile-track-article-signin-10102 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10102?target=/articles/6-68/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=10883 /> <input name=articleId type=hidden value=10102 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Edward Kim</strong>, Department of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Adrian Dobs</strong>, Department of Endocrinology, Johns Hopkins University School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Jan 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-68/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-68/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=19924-19576></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=19925-19577></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-68/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>23 Jan 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Edward Kim</strong>, Department of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Adrian Dobs</strong>, Department of Endocrinology, Johns Hopkins University School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-68/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-68/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Treatment of Hypogonadism: Current and Future...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-68/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-68/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-68/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Thirumalai A et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-68/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-68",
            templates : {
                twitter : "Treatment of Hypogonadism: Current and Future Therapies. Thirumalai A et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-68/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Treatment of Hypogonadism: Current and Future Therapies", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Treatment of Hypogonadism: Current and Future Therapies", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/10102/10883")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "10883");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "19576": 0,
                           "19577": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "eaf4e9ab-9411-421a-ab22-ffbc4d9725d4";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-68.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-68.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-68.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-68.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-68.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>